Cipta Selera Murni Tbk. vs Merck Tbk. — how do they compare? Cipta Selera Murni Tbk. trades at Rp76 (market cap 61.2B, 36.44M 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 27.2K 24h volume). The key difference: Merck Tbk. is far larger — about 27.8× Cipta Selera Murni Tbk.'s market cap, and Cipta Selera Murni Tbk. is more actively traded (36.44M versus 27.2K). Which is the better fit depends on your goals.
| CSMI | MERK | |
|---|---|---|
Market Cap | 61.2B | 1.7T |
Volume | 36.44M | 27.2K |
Lot | 364.39K | 272 |
Turnover | 2.86B | 104.39M |
Average Price | 78.5 | 3,837.87 |
Value | 2.86B | 104.39M |
Indicative Equilibrium Price | 75 | 3,850 |
Indicative Equilibrium Volume | 56.1K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Selera Murni Tbk (Company) was established based on Notarial Deed No. 167 dated July 25,1983 of Winanto Wiryomartani, S.H., in Jakarta.
Read more on CSMI →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →